Recurrence score testing does not appear to benefit patients with Grade 1, progesterone receptor-positive breast cancers: An opportunity to eliminate overtreatment and decrease testing costs

ALERT: A cyber incident at Optum/Change Healthcare may delay Luminis Health bill processing. Watch for fraud and verify any concerning messages with your provider's office. We are working to minimize disruptions.

Primary Author not in Drupal

Sibia US

Title of the Project

Recurrence score testing does not appear to benefit patients with Grade 1, progesterone receptor-positive breast cancers: An opportunity to eliminate overtreatment and decrease testing costs

Service Line in Drupal

Oncology

Format of the Project

Journal Article

Affiliated Specialties in Drupal

Surgical Oncology

Name of Publication

Hematol Oncol Stem Cell Ther

Date of Publication

Thu, 06/17/2021 - 12:00